Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director Kevin H. Roche sold 400 shares of the company’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $28.60, for a total transaction of $11,440.00. Following the completion of the transaction, the director now owns 126,384 shares in the company, valued at $3,614,582.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of Tactile Systems Technology, Inc. (TCMD) traded down $0.53 during trading on Wednesday, reaching $26.66. 178,455 shares of the company’s stock were exchanged, compared to its average volume of 203,962. The firm has a market capitalization of $495.83, a P/E ratio of 186.73, a price-to-earnings-growth ratio of 4.59 and a beta of -0.69. Tactile Systems Technology, Inc. has a 12-month low of $14.37 and a 12-month high of $37.88.

Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings data on Tuesday, November 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. The firm had revenue of $28.28 million for the quarter, compared to the consensus estimate of $27.66 million. Tactile Systems Technology had a net margin of 5.84% and a return on equity of 4.75%. The business’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.01 earnings per share. analysts expect that Tactile Systems Technology, Inc. will post 0.31 earnings per share for the current year.

Several research firms recently commented on TCMD. BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Monday, September 18th. Zacks Investment Research upgraded shares of Tactile Systems Technology from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research note on Thursday, August 10th. Northland Securities restated a “hold” rating and issued a $31.50 price target on shares of Tactile Systems Technology in a research note on Monday, October 16th. Guggenheim began coverage on shares of Tactile Systems Technology in a research note on Thursday, October 12th. They issued a “buy” rating and a $47.00 price target on the stock. Finally, Canaccord Genuity restated a “buy” rating and issued a $37.00 price target (up from $28.00) on shares of Tactile Systems Technology in a research note on Tuesday, August 8th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Tactile Systems Technology presently has an average rating of “Buy” and an average target price of $34.25.

Institutional investors have recently made changes to their positions in the business. JPMorgan Chase & Co. grew its stake in Tactile Systems Technology by 39.3% during the second quarter. JPMorgan Chase & Co. now owns 4,435 shares of the company’s stock worth $127,000 after buying an additional 1,252 shares in the last quarter. Bank of America Corp DE grew its stake in Tactile Systems Technology by 1,118.5% during the first quarter. Bank of America Corp DE now owns 6,982 shares of the company’s stock worth $133,000 after buying an additional 6,409 shares in the last quarter. Bank of Montreal Can acquired a new stake in Tactile Systems Technology during the second quarter worth about $146,000. Nationwide Fund Advisors grew its stake in Tactile Systems Technology by 201.8% during the second quarter. Nationwide Fund Advisors now owns 5,170 shares of the company’s stock worth $148,000 after buying an additional 3,457 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its stake in Tactile Systems Technology by 10,882.4% during the second quarter. The Manufacturers Life Insurance Company now owns 7,468 shares of the company’s stock worth $213,000 after buying an additional 7,400 shares in the last quarter. Hedge funds and other institutional investors own 71.68% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Tactile Systems Technology, Inc. (TCMD) Director Sells $11,440.00 in Stock” was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/06/tactile-systems-technology-inc-tcmd-director-sells-11440-00-in-stock.html.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.

Insider Buying and Selling by Quarter for Tactile Systems Technology (NASDAQ:TCMD)

Receive News & Ratings for Tactile Systems Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.